Influenza vaccines may protect against cardiovascular diseases: The evidence is mounting and should be known by the Canadian public health community
The objective of this short commentary is to alert the Canadian public health community and to provide information that could be used at the field level to promote the usefulness of influenza vaccines.PMID:38481651 | PMC:PMC10936748 | DOI:10.14745/ccdr.v49i10a04 (Source: Can Commun Dis Rep)
Source: Can Commun Dis Rep - March 14, 2024 Category: Infectious Diseases Authors: Philippe De Wals Micha ël Desjardins Source Type: research
Influenza vaccines may protect against cardiovascular diseases: The evidence is mounting and should be known by the Canadian public health community
The objective of this short commentary is to alert the Canadian public health community and to provide information that could be used at the field level to promote the usefulness of influenza vaccines.PMID:38481651 | PMC:PMC10936748 | DOI:10.14745/ccdr.v49i10a04 (Source: Can Commun Dis Rep)
Source: Can Commun Dis Rep - March 14, 2024 Category: Infectious Diseases Authors: Philippe De Wals Micha ël Desjardins Source Type: research
Influenza vaccines may protect against cardiovascular diseases: The evidence is mounting and should be known by the Canadian public health community
The objective of this short commentary is to alert the Canadian public health community and to provide information that could be used at the field level to promote the usefulness of influenza vaccines.PMID:38481651 | PMC:PMC10936748 | DOI:10.14745/ccdr.v49i10a04 (Source: Can Commun Dis Rep)
Source: Can Commun Dis Rep - March 14, 2024 Category: Infectious Diseases Authors: Philippe De Wals Micha ël Desjardins Source Type: research
Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond
CONCLUSION: The articles emphasize the need for government leadership, strategic policymaking, and public awareness to enhance vaccine coverage and equity. The VaxLab will continue strengthening China's NIP by focusing on vaccine financing, emphasizing diversity, equity, and inclusion, and improving maternal vaccination coverage. Research will extend to Southeast Asian and Western Pacific regions, especially in middle-income countries facing challenges in vaccine financing and delivery. The collective efforts outlined in this collection show a commitment to evolving and adapting immunization strategies to meet global healt...
Source: Cancer Control - March 13, 2024 Category: Cancer & Oncology Authors: Shu Chen Lance E Rodewald Anna Heng Du Shenglan Tang Source Type: research
Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond
ConclusionThe articles emphasize the need for government leadership, strategic policymaking, and public awareness to enhance vaccine coverage and equity. The VaxLab will continue strengthening China ’s NIP by focusing on vaccine financing, emphasizing diversity, equity, and inclusion, and improving maternal vaccination coverage. Research will extend to Southeast Asian and Western Pacific regions, especially in middle-income countries facing challenges in vaccine financing and delivery. The co llective efforts outlined in this collection show a commitment to evolving and adapting immunization strategies to meet global hea...
Source: Infectious Diseases of Poverty - March 13, 2024 Category: Infectious Diseases Source Type: research
Serotype distribution and antimicrobial resistance of pediatric Streptococcus pneumoniae isolated from inpatients and outpatients at Beijing Children's Hospital
CONCLUSIONS: Pneumococcal vaccine-related serotypes are prevalent among both inpatients and outpatients, especially among inpatients, who exhibit more severe antibiotic resistance. Therefore, universal immunization with PCV13 would decrease the hospitalization rate due to S. pneumoniae and the antibiotic resistance rate of S. pneumoniae.PMID:38471654 | DOI:10.1016/j.bjid.2024.103734 (Source: Braz J Infect Dis)
Source: Braz J Infect Dis - March 12, 2024 Category: Infectious Diseases Authors: Shuang Lyu Wei Shi Fang Dong Bao Ping Xu Gang Liu Quan Wang Kai Hu Yao Yong Hong Yang Source Type: research
Serotype distribution and antimicrobial resistance of pediatric Streptococcus pneumoniae isolated from inpatients and outpatients at Beijing Children's Hospital
CONCLUSIONS: Pneumococcal vaccine-related serotypes are prevalent among both inpatients and outpatients, especially among inpatients, who exhibit more severe antibiotic resistance. Therefore, universal immunization with PCV13 would decrease the hospitalization rate due to S. pneumoniae and the antibiotic resistance rate of S. pneumoniae.PMID:38471654 | DOI:10.1016/j.bjid.2024.103734 (Source: Braz J Infect Dis)
Source: Braz J Infect Dis - March 12, 2024 Category: Infectious Diseases Authors: Shuang Lyu Wei Shi Fang Dong Bao Ping Xu Gang Liu Quan Wang Kai Hu Yao Yong Hong Yang Source Type: research
Investigation into the safety, and serological responses elicited by delivery of live intranasal vaccines for bovine herpes virus type 1, bovine respiratory syncytial virus, and parainfluenza type 3 in pre-weaned calves
The objective of this study was to use a cohort of 40 dairy and dairy-beef female and male calves (27 females and 13 males) to determine serological responses to concurrent administration at 3 weeks of age (22 ± 4.85 days) of two commercially available intranasal (IN) vaccines for the viruses: bovine respiratory syncytial virus (BRSV), bovine herpes virus 1 (BoHV-1), and parainfluenza-3-virus (PI3-V). The study groups were as follows: (i) Bovilis IBR Marker Live only® (IO), (ii) Bovilis INtranasal RSP Live® only (RPO), (iii) Concurrent vaccination with Bovilis IBR Marker Live® & Bovilis Intranasal RSP Live® (CV), ...
Source: Herpes - March 11, 2024 Category: Infectious Diseases Authors: Anna Flynn Catherine McAloon Katie Sugrue Ricki Fitzgerald Cara Sheridan Bosco Cowley Conor McAloon Emer Kennedy Source Type: research
A Pediatric Investigators Collaborative Network on Infections in Children (PICNIC) multi-centre Canadian descriptive analysis of < em > Haemophilus influenzae < /em > bacteremia in children: Emerging serotypes
CONCLUSION: In the era of efficacious conjugate Hib vaccines, NTHi, Hia and Hif have emerged as the leading causes of invasive Hi in Canadian children, with Hia being most likely to result in meningitis and complicated disease. A vaccine for all NTHi and THi would be ideal, but knowledge of the current disease burden from circulating strains will inform prioritization of vaccine targets.PMID:38463901 | PMC:PMC10919449 | DOI:10.14745/ccdr.v49i09a02 (Source: Can Commun Dis Rep)
Source: Can Commun Dis Rep - March 11, 2024 Category: Infectious Diseases Authors: Craig Frankel Joan Robinson Sarah Khan Mohammad Alghounaim Jane McDonald Alison Lopez Sergio Fanella John Gunawan Jacqueline Wong Jeannette Comeau Jennifer Bowes Robert Slinger Angela Kalia Ashley Roberts Kirk Leifso Marina Ulanova Michelle Barton Source Type: research
A Pediatric Investigators Collaborative Network on Infections in Children (PICNIC) multi-centre Canadian descriptive analysis of < em > Haemophilus influenzae < /em > bacteremia in children: Emerging serotypes
CONCLUSION: In the era of efficacious conjugate Hib vaccines, NTHi, Hia and Hif have emerged as the leading causes of invasive Hi in Canadian children, with Hia being most likely to result in meningitis and complicated disease. A vaccine for all NTHi and THi would be ideal, but knowledge of the current disease burden from circulating strains will inform prioritization of vaccine targets.PMID:38463901 | PMC:PMC10919449 | DOI:10.14745/ccdr.v49i09a02 (Source: Can Commun Dis Rep)
Source: Can Commun Dis Rep - March 11, 2024 Category: Infectious Diseases Authors: Craig Frankel Joan Robinson Sarah Khan Mohammad Alghounaim Jane McDonald Alison Lopez Sergio Fanella John Gunawan Jacqueline Wong Jeannette Comeau Jennifer Bowes Robert Slinger Angela Kalia Ashley Roberts Kirk Leifso Marina Ulanova Michelle Barton Source Type: research
Current vaccine strategies and novel approaches to combatting Francisella infection
Vaccine. 2024 Mar 8:S0264-410X(24)00264-0. doi: 10.1016/j.vaccine.2024.02.086. Online ahead of print.ABSTRACTTularemia is caused by subspecies of Francisella tularensis and can manifest in a variety of disease states, with the pneumonic presentation resulting in the greatest mortality. Despite decades of research, there are no approved vaccines against F. tularensis in the United States. Traditional vaccination strategies, such as live-attenuated or subunit vaccines, are not favorable due to inadequate protection or safety concerns. Because of this, novel vaccination strategies are needed to combat tularemia. Here we discu...
Source: Vaccine - March 9, 2024 Category: Allergy & Immunology Authors: Jaikin E Harrell Chad J Roy John S Gunn James B McLachlan Source Type: research
Current vaccine strategies and novel approaches to combatting Francisella infection
Vaccine. 2024 Mar 8:S0264-410X(24)00264-0. doi: 10.1016/j.vaccine.2024.02.086. Online ahead of print.ABSTRACTTularemia is caused by subspecies of Francisella tularensis and can manifest in a variety of disease states, with the pneumonic presentation resulting in the greatest mortality. Despite decades of research, there are no approved vaccines against F. tularensis in the United States. Traditional vaccination strategies, such as live-attenuated or subunit vaccines, are not favorable due to inadequate protection or safety concerns. Because of this, novel vaccination strategies are needed to combat tularemia. Here we discu...
Source: Vaccine - March 9, 2024 Category: Allergy & Immunology Authors: Jaikin E Harrell Chad J Roy John S Gunn James B McLachlan Source Type: research
Attenuated vaccine PmCQ2 Δ4555–4580 effectively protects mice against Pasteurella multocida infection
Pasteurella multocida type A (PmA) mainly causes respiratory diseases such as pneumonia in bovines, leading to great economic losses to the breeding industry. At present, there is still no effective commercial va... (Source: BMC Veterinary Research)
Source: BMC Veterinary Research - March 9, 2024 Category: Veterinary Research Authors: Fang He, Pan Xiong, Huihui Zhang, Liu Yang, Yangyang Qiu, Pan Li, Guangfu Zhao, Nengzhang Li and Yuanyi Peng Tags: Research Source Type: research
Investigation on the correlation factors of positive Streptococcus pneumoniae antibody and IgG antibody level of Streptococcus pneumoniae in the elderly over 60 years old in Shenzhen
CONCLUSION: There was a statistically significant difference in antibody positivity rates for older people with more frequent medical check-ups in Shenzhen, indicating that publicity is playing a role. The effects of age, gender, and chronic diseases on naturally acquired anti-PPS IgG differ.PMID:38458872 | DOI:10.1016/j.vaccine.2024.01.070 (Source: Vaccine)
Source: Vaccine - March 8, 2024 Category: Allergy & Immunology Authors: Lixian Su Xiaofeng Zhou Weijun Peng Jingwei Luo Qiaoxiang Lin Lizhen Liu Jian Lin Shufen Lin Kechun Zhang Hongbiao Chen Muyun Liu Source Type: research
Pneumococcal vaccination strategies in 50-year-olds to decrease racial disparities: a US societal perspective cost-effectiveness analysis
This study assesses the impact of expanding pneumococcal vaccination to all 50-year-olds to decrease racial disparities by estimating from the societal perspective, the cost-effectiveness of 20-valent pneumococcal conjugate vaccine (PCV20) and 15-valent conjugate vaccine followed by 23-valent polysaccharide vaccine (PCV15/PPSV23) for 50-year-olds. (Source: Value in Health)
Source: Value in Health - March 8, 2024 Category: International Medicine & Public Health Authors: Shoroq M. Altawalbeh, Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman, Kenneth J. Smith Source Type: research
